Roman A. Zubarev

ORCID: 0000-0001-9839-2089 · 2 papers in corpus · active 2021-2023

Study types

  • article 2

Condition tags

  • endometriosis 2
article 2023
Distinct molecular targets of ProEGCG from EGCG and superior inhibition of angiogenesis signaling pathways for treatment of endometriosis
Journal of pharmaceutical analysis ·doi:10.1016/j.jpha.2023.09.005

Endometriosis is a common chronic gynecological disease with endometrial cell implantation outside the uterus. Angiogenesis is a major pathophysiology in endometriosis. Our previous studies have demonstrated that the prodrug of epigallocate…

article 2021
O-145 Green Tea catechins EGCG and pro-drug of EGCG (Pro-EGCG) inhibit endometriosis through targeting molecules regulating macrophages and B cells
·doi:10.1093/humrep/deab127.013

Abstract Study question What are the therapeutic targets and mechanisms of green tea EGCG and Pro-EGCG in treating endometriosis? Summary answer EGCG and Pro-EGCG have unique molecular targets to regulate interactions of B cells, macrophage…